USCAP Honors

Benjamin Castleman Award
YearAwardee
2016Benjamin H. Durham
2015Mark J. Kiel
2014Valetina Nardi
2013Abner Louissaint
2012Daniel Winer
2011Jiaqi Shi
2011Anthony Gill
2010Adeboye Osunkoya
2009Kirsten D. Mertz
2008Laurence de Leval
2007Adebowale Joel Adeniran
2006Arul M. Chinnaiyan
2005Andrew P. Weng
2004Anirban Maitra
2003Jerome T. O'Connell
2002David G. Huntsman
2001Todd Kroll
2000Daniel J. Brat
1999Irina Lubensky
1998Jeffrey K. Taubenberger
1997Sarah S. Frankel
1996Frederic G. Barr
1995Marc Ladanyi
1994Cheryl L. Willman
1993Timothy J. McDonnell
1992Giorgio Ingrahami
1991Peter A. Humphrey
1990Ivan Stamenkovic
1989Stephen Chalmer Peiper
1988John Anastasi
1987James T. Kurnick
1986Lawrence M. Weiss
1985Ann D. Thor
1984George F. Murphy
1983Renato V. Iozzo
1982William E. Beschorner
1981Roger Warnke

Massachusetts General Hospital and the United States and Canadian Academy of Pathology

The Benjamin Castleman Award  is granted for an outstanding paper in the field of human pathology published in English. Selections made by the Benjamin Castleman Award Committee will be based on the merit of the submitted paper, not on the entire career of the author. Please do not include additional supporting papers. Any optional information or letters from sponsors should be focused on the paper, not on the author’s qualifications. The 2017 award will be based on papers published during the calendar year 2016. The subject may represent any topic in pathology, but must be directly relevant to human disease. On papers with multiple authors, only one author is eligible, and only one paper per author may be submitted.

The awardee must be an individual whose year of birth is 1977 or later and who is in, or has completed, a pathology house staff training program in a Board Certified Specialty of Pathology. Papers by pathology trainees are encouraged. The prize will consist of a check for $1,500 and a certificate. Funds for travel are not included and the awardee does not have to be present at the Annual Meeting.

Applicants should complete the application form available by clicking here, and electronically submit the form along with a reprint (or preprint) of their manuscript to denice@uscap.org . This award, financed by contributions to a fund established by former students and trainees of Dr. Castleman, will be presented on Tuesday, March 7, 2017 during the USCAP Annual Meeting in San Antonio, Texas.

 

Submit completed form and reprint (or preprint) of paper by email to Denice Chinn at denice@uscap.org.

Note:  The deadline for The Benjamin Castleman Award is Saturday, October 15, 2016. 

Most-Recent Awardee

Benjamin H. Durham, M.D.

Dr. Benjamin H. Durham was born in the southeastern United States. He received his Bachelor of Science degree in biochemistry and molecular biology from the University of Alabama at Birmingham and his M.D. from the University of Alabama School of Medicine, Birmingham, AL, in 2007. He completed his anatomic and clinical pathology residency at St. Louis University School of Medicine, St. Louis, MO, under the directorship of David S. Brink, M.D. with subsequent board certification in anatomic pathology and clinical pathology. His hematopathology fellowship was at the University of California, Davis, School of Medicine, Sacramento, CA, under the directorship of Denis M. Dwyre, M.D. with subsequent subspecialty board certification in hematopathology. He then completed his molecular genetic pathology fellowship at Columbia University College of Physicians and Surgeons and the New York Presbyterian Hospital, New York, NY, under the directorship of Mahesh M. Mansukhani, M.D. with subsequent subspecialty board certification in molecular genetic pathology. He is currently a genomic pathology research fellow in molecular oncology at Memorial Sloan Kettering Cancer Center and the Sloan Kettering Institute under the directorship of Marc Ladanyi, M.D. As part of this unique and newly designed experimental pathology program for the development of pathology-trained, physician-scientists at Memorial Sloan Kettering Cancer Center, Dr. Durham studies the molecular hematopathology and functional genomics of poorly characterized hematopoietic malignancies under the co-mentorship of Christopher Y. Park, M.D., Ph.D., a hematopathologist and stem cell biologist, and Omar Abdel-Wahab, M.D., a hematologist and cancer biologist.

During his genomic pathology research fellowship in molecular oncology that started in 2014, Dr. Durham has received invitations to present data publically at national and international meetings of the American Society of Hematology, the United States and Canadian Academy of Pathology, the Histiocyte Society, and the Erdheim-Chester Disease Global Alliance from his and his co-authors' paper entitled "Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms" that has recently been published in Cancer Discovery. Dr. Durham has also received several honors during the course of this work that include a Senior Investigator Research Training Award for Fellows and an abstract achievement award from the American Society of Hematology, a 2015 Stowell-Orbison Award Certificate of Merit from the United States and Canadian Academy of Pathology, the 2015 Pathologist-in-Training (PIT) Award from the Society for Hematopathology, the 2015 Nezelof Prize in Basic Science from the Histiocyte Society, and his selection to present this work as the keynote address at the 2015 International Erdheim-Chester Disease Medical Symposium. Currently, Dr. Durham is working on the functional genomic characterization of the histiocytic and dendritic cell neoplasms and other poorly characterized hematopoietic disorders.

About

view more